Assessment of the relative systemic potency of inhaled fluticasone and budesonide

Studies using dry powder devices have suggested that fluticasone propionate (FP) has a greater systemic effect than budesonide (BUD). The aim of the present study was to investigate and compare the relative systemic potency of FP and BUD from their respective pressurized metered-dose inhalers (pMDIs). A placebo-controlled, open, randomized, cross-over study was conducted in 21 healthy male volunteers. Placebo, BUD (200, 400 and 1,000 micrograms b.i.d.) and FP (200, 375 and 1,000 micrograms b.i.d.) were inhaled for 4 days, with a wash-out period of at least 3 days between treatments. Blood samples for cortisol analysis were drawn during the last 24 h of each treatment period. Cortisol levels, measured as 24 h pooled plasma cortisol, were statistically significantly lower (p = 0.0001) for all dose levels during FP pMDI treatment (21, 39 and 84% suppression from placebo) than during BUD pMDI treatment (1, 3 and 27% suppression from placebo). The relative systemic potency FP:BUD was 3.7:1 (95% confidence interval (95% CI) 2.9-4.8)). The relative systemic potency based on the single 08:00 h samples was 5.2:1 (95% CI 3.0-9.3). In conclusion, in healthy male volunteers using pressurized metered-dose inhalers, fluticasone propionate was shown to have a stronger systemic effect than budesonide.

This article has been cited by other articles:

				L Smeeth, M Boulis, R Hubbard, and A E Fletcher A population based case-control study of cataract and inhaled corticosteroids Br. J. Ophthalmol., October 1, 2003; 87(10): 1247 - 1251. [Abstract] [Full Text] [PDF]

				T W Harrison and A E Tattersfield Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects Thorax, March 1, 2003; 58(3): 258 - 260. [Abstract] [Full Text] [PDF]

				R. J. Martin, S. J. Szefler, V. M. Chinchilli, M. Kraft, M. Dolovich, H. A. Boushey, R. M. Cherniack, T. J. Craig, J. M. Drazen, J. K. Fagan, et al. Systemic Effect Comparisons of Six Inhaled Corticosteroid Preparations Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1377 - 1383. [Abstract] [Full Text] [PDF]

				B J LIPWORTH, T HARRISON, A TATTERSFIELD, S A MCKENZIE, T HARRISON, and A TATTERSFIELD Systemic effects of inhaled steroids Thorax, December 1, 2001; 56(12): 980b - 981. [Full Text] [PDF]

				T W Harrison, A Wisniewski, J Honour, and A E Tattersfield Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects Thorax, March 1, 2001; 56(3): 186 - 191. [Abstract] [Full Text]

				P.L.P. Brand Inhaled corticosteroids reduce growth. Or do they? Eur. Respir. J., February 1, 2001; 17(2): 287 - 294. [Abstract] [Full Text] [PDF]

				L. P. NIELSEN and R. DAHL Therapeutic Ratio of Inhaled Corticosteroids in Adult Asthma . A Dose-Range Comparison between Fluticasone Propionate and Budesonide, Measuring Their Effect on Bronchial Hyperresponsiveness and Adrenal Cortex Function Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2053 - 2057. [Abstract] [Full Text]

				P. J. Sharek and D. A. Bergman The Effect of Inhaled Steroids on the Linear Growth of Children With Asthma: A Meta-analysis Pediatrics, July 1, 2000; 106(1): 8e - 8. [Abstract] [Full Text]

				L. P. Nielsen, R. Dahl, E. Derom, and R. Pauwels Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2115 - 2115. [Full Text]

				M. Brutsche-Carlen, I. Carlen-Brutsche, and A. Woodcock Absorption of High-Dose Inhaled Corticosteroids Chest, May 1, 2000; 117(5): 1526 - 1526. [Full Text] [PDF]

				O. J. Dempsey, A. M. Wilson, W. J. R. Coutie, and B. J. Lipworth Evaluation of the Effect of a Large Volume Spacer on the Systemic Bioactivity of Fluticasone Propionate Metered-Dose Inhaler Chest, October 1, 1999; 116(4): 935 - 940. [Abstract] [Full Text] [PDF]

				R. Brus Effects of High-Dose Inhaled Corticosteroids on Plasma Cortisol Concentrations in Healthy Adults Arch Intern Med, September 13, 1999; 159(16): 1903 - 1908. [Abstract] [Full Text] [PDF]

				E. DEROM, J. VAN SCHOOR, W. VERHAEGHE, W. VINCKEN, and R. PAUWELS Systemic Effects of Inhaled Fluticasone Propionate and Budesonide in Adult Patients with Asthma Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 157 - 161. [Abstract] [Full Text]

				B. J. Lipworth Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis Arch Intern Med, May 10, 1999; 159(9): 941 - 955. [Abstract] [Full Text] [PDF]

				B. J Lipworth Fortnightly review: Modern drug treatment of chronic asthma BMJ, February 6, 1999; 318(7180): 380 - 384. [Full Text]

				J. W. Georgitis The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of Asthma Chest, January 1, 1999; 115(1): 210 - 217. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				R Donnelly, K. Williams, A. Baker, C. Badcock, R. Day, and J. Seale Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1746 - 1751. [Abstract] [Full Text]

				A. M. WILSON, L. C. MCFARLANE, and B. J. LIPWORTH Dose-response Effect for Adrenal Suppression with Repeated Twice Daily Inhaled Fluticasone Propionate and Triamcinolone Acetonide in Adult Asthmatics Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1274 - 1277. [Abstract] [Full Text] [PDF]